中文版 | English

在结果中检索

IOCAS-IR

浏览/检索结果: 共59条，第1-10条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Fucoidan may treat jellyfish dermatitis by inhibiting the inflammatory effect of jellyfish venom 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 卷号: 253, 页码: 13
作者:  Li, Aoyu;  Yue, Yang;  Li, Rongfeng;  Yu, Chunlin;  Wang, Xueqin;  Liu, Song;  Xing, Ronge;  Li, Pengcheng;  Zhang, Quanbin;  Yu, Huahua
Adobe PDF(4528Kb)  |  收藏  |  浏览/下载：3/0  |  提交时间：2024/04/07
Fucoidan  Jellyfish dermatitis  Jellyfish envenomation  
Fucoidan, as an immunostimulator promotes M1 macrophage differentiation and enhances the chemotherapeutic sensitivity of capecitabine in colon cancer 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 卷号: 222, 页码: 562-572
作者:  Deng, Zhenzhen;  Wu, Ning;  Suo, Qishan;  Wang, Jing;  Yue, Yang;  Geng, Lihua;  Zhang, Quanbin
Adobe PDF(8782Kb)  |  收藏  |  浏览/下载：142/0  |  提交时间：2023/01/04
Capecitabine  Tumor microenvironment  Macrophages  TLR4  Fucoidan  
Low molecular weight fucoidan fraction LF2 improves metabolic syndrome via up-regulating PI3K-AKT-mTOR axis and increasing the abundance of Akkermansia muciniphila in the gut microbiota 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 卷号: 193, 页码: 789-798
作者:  Deng, Zhenzhen;  Wu, Ning;  Wang, Jing;  Geng, Lihua;  Yue, Yang;  Wang, Fahe;  Zhang, Quanbin
Adobe PDF(3607Kb)  |  收藏  |  浏览/下载：180/0  |  提交时间：2022/02/18
Fucoidan  Metabolic syndrome  Gut microbiota  
Low molecular weight fucoidan attenuating pulmonary fibrosis by relieving inflammatory reaction and progression of epithelial-mesenchymal transition 期刊论文
CARBOHYDRATE POLYMERS, 2021, 卷号: 273, 页码: 10
作者:  Wu, Ning;  Li, Zhi;  Wang, Jing;  Geng, Lihua;  Yue, Yang;  Deng, Zhenzhen;  Wang, Qingchi;  Zhang, Quanbin
Adobe PDF(3732Kb)  |  收藏  |  浏览/下载：178/0  |  提交时间：2021/12/02
Fucoidans  COVID-19  Pulmonary fibrosis  Epithelial-mesenchymal transition  TGF-beta  PI3K/AKT pathway  
Dietary fibers extracted from Saccharina japonica can improve metabolic syndrome and ameliorate gut microbiota dysbiosis induced by high fat diet 期刊论文
JOURNAL OF FUNCTIONAL FOODS, 2021, 卷号: 85, 页码: 11
作者:  Deng, Zhenzhen;  Wu, Ning;  Wang, Jing;  Zhang, Quanbin
Adobe PDF(5410Kb)  |  收藏  |  浏览/下载：183/0  |  提交时间：2021/11/30
Dietary fiber  Insulin resistance  Metabolic syndrome  Gut microbiota  
Proteoglycan from Bacillus sp. BS11 Inhibits the Inflammatory Response by Suppressing the MAPK and NF-kappa B Pathways in Lipopolysaccharide-Induced RAW264.7 Macrophages 期刊论文
MARINE DRUGS, 2020, 卷号: 18, 期号: 12, 页码: 16
作者:  Wang, Qingchi;  Liu, Weixiang;  Yue, Yang;  Sun, Chaomin;  Zhang, Quanbin
Adobe PDF(2652Kb)  |  收藏  |  浏览/下载：233/0  |  提交时间：2021/04/12
Bacillus sp  proteoglycan  anti-inflammation  macrophages  
Degradation of different molecular weight fucoidans and their inhibition of TGF-beta 1 induced epithelial-mesenchymal transition in mouse renal tubular epithelial cells 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 卷号: 151, 页码: 545-553
作者:  Li, Xiaosong;  Wu, Ning;  Chen, Yongqiang;  Tan, Jiaojiao;  Wang, Jing;  Geng, Lihua;  Qin, Yimin;  Zhang, Quanbin
Adobe PDF(2869Kb)  |  收藏  |  浏览/下载：184/0  |  提交时间：2020/09/23
Degradation  Fucoidan  Epithelial-mesenchymal transition  Kidney fibrosis  
Low molecular weight fucoidan alleviates diabetic nephropathy by binding fibronectin and inhibiting ECM-receptor interaction in human renal mesangial cells 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 卷号: 150, 页码: 304-314
作者:  Wang, Jing;  Zhang, Quanbin;  Li, Shuang;  Chen, Zhihang;  Tan, Jiaojiao;  Yao, Jianting;  Duan, Delin
Adobe PDF(2307Kb)  |  收藏  |  浏览/下载：167/0  |  提交时间：2020/09/23
Fucoidan  ECM-receptor interaction  Fibronectin  
Comparative Study of Fucoidan from Saccharina japonica and Its Depolymerized Fragment on Adriamycin-Induced Nephrotic Syndrome in Rats 期刊论文
MARINE DRUGS, 2020, 卷号: 18, 期号: 3, 页码: 10
作者:  Tan, Jiaojiao;  Wang, Jing;  Geng, Lihua;  Yue, Yang;  Wu, Ning;  Zhang, Quanbin
Adobe PDF(401Kb)  |  收藏  |  浏览/下载：193/0  |  提交时间：2020/09/23
fucoidan  low-molecular-weight fucoidan  adriamycin  nephrotic syndrome  
Use of fucoidan to treat renal diseases: A review of 15 years of clinic studies 期刊论文
GLYCANS AND GLYCOSAMINOGLYCANS AS CLINICAL BIOMARKERS AND THERAPEUTICS, PT B, 2019, 卷号: 163, 页码: 95-111
作者:  Wang, Jing;  Geng, Lihua;  Yue, Yang;  Zhang, Quanbin
Adobe PDF(399Kb)  |  收藏  |  浏览/下载：233/0  |  提交时间：2020/01/03